Development of New Pharmacological Test Methods Using Human iPS Cell-Derived Cardiomyocytes

Folia Pharmacologica Japonica - Japan
doi 10.1254/fpj.149.110
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Revealing Potential Cardiac Manifestation of ADPKD Using iPS Cell-Derived Cardiomyocytes

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Development of Novel Therapies Using Human iPS Cell-Derived Retinal Pigment Epithelia

Folia Pharmacologica Japonica
Pharmacology
2016English

Adrenergic Stress Protection of Human iPS Cell-Derived Cardiomyocytes by Fast Kv7.1 Recycling

Frontiers in Physiology
Physiology
2017English

Analysis of Contractile Functions of Human iPS-derived Cardiomyocytes Using Motion Field Imaging

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Integration Capacity of Human iPS Cell-Derived Cartilage

Tissue Engineering - Part A.
BiochemistryBioengineeringBiomedical EngineeringBiomaterials
2019English

Modelling Cadmium-Induced Cardiotoxicity Using Human Pluripotent Stem Cell-Derived Cardiomyocytes

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

Β-Adrenergic Pathway Is Enhanced by Hormone-Induced Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (iPS-CM)

Biophysical Journal
Biophysics
2019English

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2018English

Screening for Diabetic Cardiomyopathy (DCM) Therapies in Induced Pluripotent Stem (iPS) Cell–derived Cardiomyocytes

Science-Business eXchange
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy